NPCE NEUROPACE INC Investments/Divestments 8-K Filing 2023 - Collaboration Agreement with Rapport Therapeutics NeuroPace Inc entered into a collaboration agreement with Rapport Therapeutics for a Phase 2a trial, with anticipated revenue of $3.7 million.Get access to all SEC 8-K filings of the NEUROPACE INC